Veraxa Biotech Holding AG (VRXA) Current Assets (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Current Assets came in at $3.6 million in Q4 2025, down 43.61% year-on-year from $6.4 million in Q4 2024, and down 43.61% on a QoQ basis from $6.4 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Current Assets (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Current Assets data on file, last reported at $3.6 million in Q4 2025.
- On a quarterly basis, Current Assets fell 43.61% year-over-year to $3.6 million in Q4 2025; TTM through Dec 2025 was $3.6 million, a 43.61% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 43.61% from the prior year.
- Current Assets for Q4 2025 stood at $3.6 million, down from $6.4 million in the prior quarter.
- Over the last five years, Current Assets for VRXA reached as high as $6.4 million in Q4 2024 and fell as low as $3.6 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 6.40 Mn |